AIDA TRIVIC: Open Payments
NPI 1386971323 · HILLSBORO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,051 in 53 payments from 19 companies in 2025. Trend: 2023 $1,324 · 2024 $1,406 · 2025 $3,051
Consulting: $1,750Food & beverage: $1,301
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $1,987 |
| ViiV Healthcare Company | 13 | $309 |
| Napo Pharmaceuticals Inc | 6 | $135 |
| PFIZER INC. | 6 | $113 |
| ABBVIE INC. | 3 | $72 |
| Novo Nordisk Inc | 4 | $72 |
| SANOFI-AVENTIS U.S. LLC | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Lilly USA, LLC | 2 | $42 |
| Almatica Pharma LLC | 2 | $35 |
Products named: Yeztugo, APRETUDE, Mytesi, CABENUVA, TZIELD, ELIQUIS, PIFELTRO, MOUNJARO.
Industry payments across MO — which companies pay providers there.
